Kymera Therapeutics CBO Noah Goodman sells $247,500 in stock
AI Summary
Kymera Therapeutics Chief Business Officer Noah Goodman sold $247,500 worth of company stock. The report provides insights into insider trading activity within the firm.
Kymera Therapeutics Chief Business Officer Noah Goodman sold $247,500 worth of company stock. The report provides insights into insider trading activity within the firm.
Khmer Times —
The Sydney Morning Herald —
The Guardian —
Globo Esporte Brazil —
Globo Esporte Brazil —
The Guardian —